Healthcare - Biotechnology - NASDAQ - CN
$ 1.04
-2.8 %
$ 80.1 M
Market Cap
-0.46
P/E
CASH FLOW STATEMENT
-184 M
OPERATING CASH FLOW
103 M
INVESTING CASH FLOW
7.57 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
I-Mab
| Net Income | -207 M |
| Depreciation & Amortization | 7.44 M |
| Capital Expenditures | -1.6 M |
| Stock-Based Compensation | 193 M |
| Change in Working Capital | -44.8 M |
| Others | -1.3 B |
| Free Cash Flow | -1.32 B |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||
| Net Income | (206.8) | (2 507.3) | (2 331.5) | 470.9 | (1 452.0) | (402.8) | (298.2) |
| Depreciation & Amortization | 7.4 | 63.8 | 34.1 | 23.1 | 15.6 | 6.7 | 1.6 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (6.4) | (75.0) | 8.5 |
| Stock Based Compensation | 193.0 | 357.1 | 608.6 | 493.5 | 366.9 | 3.5 | 7.0 |
| Other Operating Activities | (1 253.8) | 431.5 | 321.2 | (313.3) | 23.0 | 39.0 | 3.8 |
| Change in Working Capital | (44.8) | 552.1 | 394.5 | (240.6) | 184.8 | 147.9 | 25.0 |
| Cash From Operations | (1 305.0) | (1 102.8) | (973.1) | 433.6 | (868.0) | (280.7) | (252.2) |
| INVESTING CASH FLOW | |||||||
| Capital Expenditures | (1.6) | (45.8) | (29.9) | (8.0) | (12.2) | (14.4) | (20.3) |
| Other Items | 104.1 | 504.2 | (697.3) | (193.9) | 224.7 | 23.9 | (137.3) |
| Cash From Investing Activities | 102.5 | 458.4 | (727.2) | (201.9) | 212.5 | 9.5 | (157.7) |
| FINANCING CASH FLOW | |||||||
| Common Stock Repurchased | (9.2) | (3.1) | 0 | (34.9) | 0 | 0 | 0 |
| Total Debt Repaid | 9.9 | 2.7 | 0 | 0 | 0 | 59.7 | 111.3 |
| Dividends Paid | 0 | 0 | 0 | 0 | (5.3) | 0 | 0 |
| Other Financing Activities | 6.9 | 42.7 | 593.9 | 2 902.3 | 21.8 | 1 420.0 | 647.3 |
| Cash From Financing Activities | 7.6 | 42.4 | 593.9 | 3 440.5 | 152.7 | 1 479.7 | 758.6 |
| CHANGE IN CASH | |||||||
| Net Change In Cash | (1 110.4) | (212.9) | (1 235.1) | 3 565.5 | (487.6) | 1 268.2 | 348.6 |
| FREE CASH FLOW | |||||||
| Free Cash Flow | (1 316.3) | (1 148.6) | (1 003.0) | 425.6 | (880.2) | (295.1) | (272.5) |